Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| gamma-Cyclodextrins | 2 | 2020 | 2 | 1.260 |
Why?
|
| Cholesterol | 3 | 2020 | 230 | 1.230 |
Why?
|
| Niemann-Pick Disease, Type C | 3 | 2020 | 5 | 0.900 |
Why?
|
| Lysosomes | 2 | 2020 | 88 | 0.770 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 108 | 0.620 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 201 | 0.600 |
Why?
|
| Infant | 5 | 2023 | 1143 | 0.240 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2017 | 181 | 0.240 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2023 | 2 | 0.210 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 94 | 0.200 |
Why?
|
| Epilepsy | 1 | 2023 | 56 | 0.200 |
Why?
|
| beta-Cyclodextrins | 2 | 2018 | 35 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 42 | 0.180 |
Why?
|
| Genetic Testing | 1 | 2021 | 90 | 0.170 |
Why?
|
| Hela Cells | 2 | 2018 | 370 | 0.170 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2020 | 20 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 47 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 979 | 0.160 |
Why?
|
| Biological Transport | 1 | 2020 | 201 | 0.160 |
Why?
|
| Bronchiectasis | 1 | 2019 | 13 | 0.160 |
Why?
|
| Child | 4 | 2023 | 3381 | 0.160 |
Why?
|
| Mutism | 1 | 2019 | 1 | 0.150 |
Why?
|
| Infratentorial Neoplasms | 1 | 2019 | 1 | 0.150 |
Why?
|
| Proteomics | 2 | 2018 | 363 | 0.150 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 4 | 0.150 |
Why?
|
| Autophagy | 1 | 2020 | 136 | 0.150 |
Why?
|
| Cranial Sutures | 1 | 2018 | 2 | 0.150 |
Why?
|
| Craniosynostoses | 1 | 2018 | 3 | 0.150 |
Why?
|
| Craniotomy | 1 | 2018 | 5 | 0.150 |
Why?
|
| Endosomes | 1 | 2018 | 34 | 0.150 |
Why?
|
| Cyclodextrins | 1 | 2018 | 11 | 0.140 |
Why?
|
| Critical Care | 1 | 2018 | 48 | 0.140 |
Why?
|
| Carrier Proteins | 1 | 2020 | 318 | 0.140 |
Why?
|
| Cell Line | 2 | 2018 | 1416 | 0.140 |
Why?
|
| Protein Transport | 1 | 2018 | 295 | 0.140 |
Why?
|
| Minority Groups | 1 | 2023 | 663 | 0.140 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 5 | 0.130 |
Why?
|
| Fibrosarcoma | 1 | 2017 | 8 | 0.130 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2017 | 16 | 0.130 |
Why?
|
| Humans | 12 | 2024 | 42163 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 25 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 45 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2017 | 130 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2017 | 77 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2020 | 1617 | 0.120 |
Why?
|
| Proteins | 1 | 2018 | 383 | 0.120 |
Why?
|
| Child, Preschool | 4 | 2023 | 1516 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 287 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2019 | 467 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 2598 | 0.110 |
Why?
|
| Pteridines | 1 | 2013 | 3 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2013 | 3 | 0.100 |
Why?
|
| Neoplasms | 1 | 2024 | 1341 | 0.100 |
Why?
|
| Cytokines | 1 | 2017 | 661 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 159 | 0.090 |
Why?
|
| Brain Neoplasms | 1 | 2013 | 129 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 255 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 479 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 239 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2485 | 0.080 |
Why?
|
| India | 2 | 2019 | 105 | 0.080 |
Why?
|
| Male | 4 | 2023 | 22779 | 0.070 |
Why?
|
| Female | 4 | 2020 | 24018 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2023 | 1586 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2021 | 1574 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2017 | 115 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1679 | 0.060 |
Why?
|
| Syncope | 1 | 2023 | 4 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2023 | 14 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2023 | 21 | 0.050 |
Why?
|
| Adolescent | 3 | 2023 | 5950 | 0.050 |
Why?
|
| Seizures | 1 | 2023 | 79 | 0.050 |
Why?
|
| Genomics | 1 | 2021 | 289 | 0.040 |
Why?
|
| International Cooperation | 1 | 2019 | 51 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 114 | 0.040 |
Why?
|
| Universities | 1 | 2023 | 539 | 0.040 |
Why?
|
| Netherlands | 1 | 2019 | 12 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 24 | 0.040 |
Why?
|
| Indonesia | 1 | 2019 | 22 | 0.040 |
Why?
|
| Phenotype | 1 | 2021 | 774 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2018 | 19 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 33 | 0.040 |
Why?
|
| Skull | 1 | 2018 | 27 | 0.040 |
Why?
|
| Canada | 1 | 2019 | 157 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2018 | 84 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2018 | 29 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 45 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 727 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2017 | 2111 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 154 | 0.030 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 11 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2017 | 14 | 0.030 |
Why?
|
| Students | 1 | 2023 | 617 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2017 | 31 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 431 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 231 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 253 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 140 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2017 | 48 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 174 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 560 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 686 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 297 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 934 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 658 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 16695 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 355 | 0.030 |
Why?
|
| Mice | 2 | 2017 | 6490 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 50 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2013 | 158 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1066 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 506 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 339 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2013 | 1729 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1804 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 7982 | 0.020 |
Why?
|
| Risk Factors | 1 | 2013 | 3942 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 11819 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 13458 | 0.010 |
Why?
|